



@article {2234,
	title = {Bone marrow-derived endothelial progenitors expressing delta-like 4 (Dll4) regulate tumor angiogenesis},
	journal = {PLoS ONEPLoS ONE},
	volume = {6},
	year = {2011},
	note = {Cited By (since 1996): 8Export Date: 21 November 2012Source: ScopusArt. No.: e18323doi: 10.1371/journal.pone.0018323Language of Original Document: EnglishCorrespondence Address: Dias, S.; Angiogenesis Laboratory, CIPM/Portuguese Institute of Oncology, Lisbon, Portugal; email: sergidias@ipolisboa.min-saude.ptChemicals/CAS: fibronectin, 86088-83-7; vasculotropin, 127464-60-2; DLL4 protein, mouse; Intracellular Signaling Peptides and Proteins; Membrane ProteinsReferences: Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization (1999) Circ Res, 85, pp. 221-228;Rafii, S., Lyden, D., Benezra, R., Hattori, K., Heissig, B., Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? (2002) Nat Rev Cancer, 2, pp. 826-835. , Review; 
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth (2001) Nat Med, 7, pp. 1194-1201; 
Larrivee, B., Niessen, K., Pollet, I., Corbel, S.Y., Long, M., Minimal contribution of marrow-derived endothelial precursors to tumor vasculature (2005) J Immunol, 175, pp. 2890-2899; 
Peters, B.A., Diaz, L.A., Polyak, K., Meszler, L., Romans, K., Contribution of bone marrow-derived endothelial cells to human tumor vasculature (2005) Nat Med, 11, pp. 261-262; 
Pasquier, E., Dias, S., Endothelial progenitor cells: Hope beyond controversy (2010) Curr Cancer Drug Targets, 10 (8), pp. 914-921; 
Dudley, A.C., Udagawa, T., Melero-Martin, J.M., Shih, S.C., Curatolo, A., Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors (2010) Blood, 116 (17), pp. 2267-2271; 
Krebs, L.T., Xue, Y., Norton, C.R., Shutter, J.R., Maguire, M., Notch signaling is essential for vascular morphogenesis in mice (2000) Genes Dev, 14, pp. 1343-1352; 
Uyttendaele, H., Ho, J., Rossant, J., Kitajewski, J., Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium (2001) Proc Natl Acad Sci U S A, 98, pp. 5643-5648; 
Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Dosage-sensitive requirement for mouse Dll4 in artery development (2004) Genes Dev, 18, pp. 2474-2478; 
Gale, N.W., Dominguez, M.G., Noguera, I., Pan, L., Hughes, V., Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development (2004) Proc Natl Acad Sci U S A, 101, pp. 15949-15954; 
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele (1996) Nature, 380, pp. 435-439; 
Mailhos, C., Modlich, U., Lewis, J., Harris, A., Bicknell, R., Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis (2001) Differentiation, 69, pp. 135-144; 
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 (2004) Cancer Cell, 6, pp. 507-516; 
Patel, N.S., Li, J.L., Generali, D., Poulsom, R., Cranston, D.W., Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function (2005) Cancer Res, 65, pp. 8690-8697; 
Williams, C.K., Li, J.L., Murga, M., Harris, A.L., Tosato, G., Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function (2006) Blood, 107, pp. 931-939; 
Caiado, F., Real, C., Carvalho, T., Dias, S., Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential (2008) PLoS One, 3, pp. e3752; 
Escudier, B., Eisen, T., Stadler, W.M., Szczylik, C., Oudard, S., Sorafenib in advanced clear-cell renal-cell carcinoma (2007) N Engl J Med, 356, pp. 125-134; 
Llovet, J.M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Sorafenib in advanced hepatocellular carcinoma (2008) N Engl J Med, 359, pp. 378-390; 
Motzer, R.J., Bukowski, R.M., Targeted therapy for metastatic renal cell carcinoma (2006) J Clin Oncol, 24, pp. 5601-5608; 
Bergers, G., Hanahan, D., Modes of resistance to anti-angiogenic therapy (2008) Nat Rev Cancer, 8, pp. 592-603; 
Verheul, H.M., Pinedo, H.M., Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition (2007) Nat Rev Cancer, 7, pp. 475-485; 
Noguera-Troise, I., Daly, C., Papadopoulos, N.J., Coetzee, S., Boland, P., Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis (2006) Nature, 444, pp. 1032-1037; 
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.C., Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis (2006) Nature, 444, pp. 1083-1087; 
Moore, M.A., Hattori, K., Heissig, B., Shieh, J.H., Dias, S., Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1 (2001) Ann N Y Acad Sci, 938, pp. 36-45. , discussion 45-37; 
Yamaguchi, J., Kusano, K.F., Masuo, O., Kawamoto, A., Silver, M., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization (2003) Circulation, 107, pp. 1322-1328; 
Leslie, J.D., Ariza-McNaughton, L., Bermange, A.L., McAdow, R., Johnson, S.L., Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis (2007) Development, 134, pp. 839-844; 
Trindade, A., Kumar, S.R., Scehnet, J.S., Lopes-da-Costa, L., Becker, J., Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos (2008) Blood, 112, pp. 1720-1729; 
Huang, M.T., Mason, J.C., Birdsey, G.M., Amsellem, V., Gerwin, N., Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis (2005) Blood, 106, pp. 1636-1643; 
Deutsch, U., Schlaeger, T.M., Dehouck, B., Doring, A., Tauber, S., Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice (2008) Exp Cell Res, 314, pp. 1202-1216; 
Dias, S., Thomas, H., Balkwill, F., Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model (1998) Int J Cancer, 75 (1), pp. 151-157; 
Scott, K.A., Holdsworth, H., Balkwill, F.R., Dias, S., Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model (2000) Br J Cancer, 83 (11), pp. 1538-1543
},
	month = {2011///},
	abstract = {Neo-blood vessel growth (angiogenesis), which may involve the activation of pre-existing endothelial cells (EC) and/or the recruitment of bone marrow-derived vascular precursor cells (BM-VPC), is essential for tumor growth. Molecularly, besides the well established roles for Vascular endothelial growth factor (VEGF), recent findings show the Notch signalling pathway, in particular the ligand Delta-like 4 (Dll4), is also essential for adequate tumor angiogenesis; Dll4 inhibition results in impaired, non-functional, angiogenesis and reduced tumor growth. However, the role of BM-VPC in the setting of Notch pathway modulation was not addressed and is the subject of the present report. Here we show that SDF-1 and VEGF, which are produced by tumors, increase Dll4 expression on recruited BM-VPC. Mechanistically, BM-VPC activated, in a Dll4-dependent manner, a transcriptional program on mature EC suggestive of EC activation and stabilization. BM-VPC induced ICAM-2 and Fibronectin expression on EC, an effect that was blocked by a Dll4-specific neutralizing antibody. In vivo, transplantation of BM-VPC with decreased Dll4 into tumor-bearing mice resulted in the formation of microvessels with decreased pericyte coverage and reduced fibronectin expression. Consequently, transplantation of BM-VPC with decreased Dll4 resulted in impaired tumor angiogenesis, increased tumor hypoxia and apoptosis, and decreased tumor growth. Taken together, our data suggests that Dll4 expression by BM-VPC affects their communication with tumor vessel endothelial cells, thereby modulating tumor angiogenesis by affecting vascular stability. {\textcopyright} 2011 Real et al.},
	keywords = {angiogenesis, animal, animal cell, animal tissue, Animals, apoptosis, article, blood vessel, Blood Vessels, bone marrow, bone marrow cell, Bone Marrow Cells, cell activation, Cell Line, Tumor, cell proliferation, controlled study, cytology, delta like 4 protein, DLL4 protein, mouse, Endothelial Cells, endothelium cell, Female, Fibronectin, gene expression, gene expression regulation, genetics, human, human cell, Humans, hypoxia, in vitro study, in vivo study, intercellular adhesion molecule 2, Intracellular Signaling Peptides and Proteins, membrane protein, Membrane Proteins, metabolism, Mice, mouse, Mus, neoplasm, Neoplasms, neovascularization (pathology), Neovascularization, Pathologic, neutralizing antibody, nonhuman, Notch receptor, Pathology, pericyte, protein expression, signal peptide, solid tumor, stem cell, stem cell transplantation, Stem cells, stromal cell derived factor 1, tumor cell line, tumor growth, unclassified drug, vascularization, vasculotropin},
	isbn = {19326203 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-79953685607\&partnerID=40\&md5=60a33b7d91c1502050bc560303255881},
	author = {Real, C. and Rem{\'e}dio, L. and Caiado, F. and Igreja, C. and Borges, C. and Trindade, A. and Pinto-Do-{\'O}, P. and Yagita, H. and Duarte, A. and Dias, S.}
}
